Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-013868

Options or other derivatives

  • CEO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Woods Lori A CEO 2020-06-23 Grant or award · Stock Options (right to buy) +250,000 587,500 D
Loading xslF345X03/rdgdoc.xml…